Clinical Outcomes After Heterogeneous Overlap Stenting With Drug-Eluting Stents and Bare-Metal Stents for de Novo Coronary Artery Narrowings - 09/08/11

Doi : 10.1016/j.amjcard.2007.07.049

Jiro Aoki, MD ^a,^b, Ajay J. Kirtane, MD, SM ^a,^b, George D. Dangas, MD ^a,^b, Alexandra J. Lansky, MD ^a,^b, Andy Morales, MD ^a,^b, Masashi Kimura, MD ^a,^b, Young-Hak Kim, MD ^a,^b, Issam Moussa, MD ^a,^b, Giora Weisz, MD ^a,^b, Edward M. Kreps, MD ^a,^b, Michael Collins, MD ^a,^b, Theresa Frankin-Bond, MS ^a,^b, Gregg W. Stone, MD ^a,^b, Jeffrey W. Moses, MD ^a,^b, Martin B. Leon, MD ^a,^b, Roxana Mehran, MD ^a,^b,^⁎
^a Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York
^b Cardiovascular Research Foundation, New York, New York.

Corresponding author: Tel: 212-851-6340; fax: 212-851-9399.

Résumé

When it is difficult to deliver multiple drug-eluting stents (DES) or when size constraints limit DES implantation, bare-metal stents (BMS) may be implanted contiguous to DES. However, the clinical outcomes after overlapping DES and BMS implantation are not known. From September 2004 to June 2006, 4,872 consecutive patients who underwent percutaneous coronary intervention consented to be enrolled in a prospective registry. Of these patients, 44 (0.9%) with de novo lesions were treated with DES and BMS overlap stenting. All patients were followed to 12 months for the assessment of clinical outcomes. The average implanted stent diameter was 2.68 ± 0.30 mm for DES and 2.35 ± 0.38 mm for BMS. Overlapping BMS were implanted distal to DES in all but 1 case. One patient (2.3%) experienced acute stent thrombosis and died 2 days after the procedure. No other patient died or had a myocardial infarction during 12 months. The target vessel revascularization rate at 12 months, however, was 31.8%, mainly driven by diffuse in-stent restenosis in the BMS segments. In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization.

Le texte complet de cet article est disponible en PDF.

Plan

Methods

Results

Discussion

Export

Vol 101 - N° 1

P. 58-62 - janvier 2008 Retour au numéro

Article précédent

Outcomes of 1,090 Consecutive, Elective, Nonselected Percutaneous Coronary Interventions at a Community Hospital Without Onsite Cardiac Surgery
Andrew D. Frutkin, Sameer K. Mehta, Taral Patel, Pramod Menon, David M. Safley, John House, Charles W. Barth, J. Aaron Grantham, Steven P. Marso

| Article suivant

Short- and Long-Term Outcomes After Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts in the Drug-Eluting Stent Era
Tereza Pucelikova, Roxana Mehran, Ajay J. Kirtane, Young-Hak Kim, Martin Fahy, Giora Weisz, Alexandra J. Lansky, Issam Moussa, William A. Gray, Michael B. Collins, Susheel K. Kodali, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, George Dangas

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Clinical Outcomes After Heterogeneous Overlap Stenting With Drug-Eluting Stents and Bare-Metal Stents for de Novo Coronary Artery Narrowings - 09/08/11

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL